Regulatory Reform Committee Proposes Early Approval Plan For iPS Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
The Japanese government’s health and medicine regulatory reform committee revealed April 8 the contents of its proposal for the early approval of iPS regenerative medicine.